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O R I G I N A L  A R T I C L E
INTRODUCTION: Migraine is a chronic debilitating 
disorder having many complications including allodynia 
that affect the quality of life. Cutaneous allodynia (CA) 
refers to the comprehension of pain or discomfort in 
response to non-noxious stimuli applied to skin.1 When 
a stimulus is repeated again and again it causes 
sensitization. This process leads to early 
responsiveness by neurons.2 In facial cutaneous 
allodynia there is involvement of trigeminal nucleus 
caudalis. It has nociceptive neurons and receives 
afferent from meninges especially the dura, facial skin, 
mucosa, teeth, tongue and jaw.3,4 These neurons after 
receiving input from areas inside as well as outside the 
brain produce different responses leading to headache 
and abnormal cutaneous sensations.5 All these 
processes lead to change or alteration of normal 
electrophysiological functions of central nervous 
system as well as sensitization producing altered skin 
sensations, a condition named as cutaneous 
allodynia.6 A lot of studies done before suggest the 
prevalence of cutaneous allodynia up to 80% in 
patients with migraine especially during acute 
exacerbation.7 Those migraineurs who have more 
frequents attacks are more prone to have allodynia8, 
prevalence is more if the duration of migraine is 
prolong.9 Studies showed the presence of abnormal 
cutaneous sensations for sometimes even after the 
migraine attack has been aborted, these findings 
strengthen the mechanism of involvement of trigeminal 
pain pathway and central sensitization.10 This theory is 
also supported by the presence of symptoms in 
transformed migraine.11-13 There are three categories of 
cutaneous allodynia including thermal, dynamic 
mechanical and static mechanical.14,15 
The proposed reason for allodynia is the sensitization of 
the nociceptive neurons in central pain pathway. As 
disease progresses and its duration increases the 
frequency of allodynia also increases.  All patients were 
examined and interviews directly and by the authors 
themselves. By using the 12-items Allodynia Symptoms 
Checklist, we found the frequency percentage of 
cutaneous allodynia in migraine sufferers was up to 56 
percent with varying degrees of symptoms of allodynia 
ranging from mild to severe depending upon ASC-12 
items score. Our study is consistent with the findings of 
an international study by Lipton et al 17 that showed a 
presence of cutaneous allodynia up to 63% among 
migraineurs with severe allodynia present in 20.3% of 
migraineurs. Presence and severity of allodynia 
indicates the migraine severity actually indicating 
prompt treatment as the increased frequency of 
allodynia indicates the long term disease activity. Just 
like migraine headache that has many aggravated 
factors, cutaneous allodynia after sensitization involving 
the central process responds to even the trivial stimuli 
from inside as well as outside the brain. Young WB et al 
18 showed in their study that frequent migraine 
headache attacks are responsible for occurrence 
allodynia that favours the concept of sensitization 
leading to abnormal and enhanced dermal response to 
non irritating stimuli even. Prolonged duration of 
disorder and chronicity are related to higher 
percentages of derangements and alteration in 
processing of sensory stimuli in the cerebral cortex 19. 
So the proposed structural changes in 
trigeminovascular excitability pathway as well as some 
other pain-modulating systems in the brainstem are 
also thought to be involved in the process of happening 
of signs and symptoms of cutaneous allodynia.
In another study by Ashkenazi et al 20 on which they 
found the prevalence of allodynia in migraine patients 
up to 80%. Usually the patients become sensitive to 
pain even during attack free periods of migraine but as 
far as the allodynia is concerned when patients were 
enquired about abnormal dermal response they denied 
any symptoms of cutaneous allodynia during headache 
free periods suggesting its reversible nature.
LIMITATIONS
It is a single centre study. Frequency in non-migraine 
patients is not checked in this study. Associations of 
cutaneous allodynea especially with duration and 
severity of migraine as well as its impact on activities of 
daily living was not exercised. Validated scales for CA 
assessment not available in other languages.
CONCLUSION:
This study shows the presence and severity of allodynia 
in migraine population. Increased skin sensitivity can 
be determined by simple and relevant questioning 
about activities such as brushing hair, touching the 
scalp, shaving, and wearing glasses, contact lenses, 
earrings, or wearing tight clothes hurt patients during 
migraine attacks.
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OBJECTIVE: Objective of this study is to find out the presence and severity of cutaneous allodynia in migraine 
sufferers.
BACKGROUND: Cutaneous allodynia is the perception of pain in response to non noxious stimuli. It occurs due to 
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Headache society criteria, ICHD-3 beta, were enrolled in this study. Cutaneous allodynia was evaluated by using 
Allodynia Symptom Checklist that consisted of 12-items. Cutaneous allodynia severity was defined according to score 
i.e No allodynia if score was 0-2, mild allodynia if score was 3-5, moderate allodynia if score was 6-8 and severe 
allodynia with a score of 9 or more.
RESULTS: A total of 200 patients were enrolled in study with a mean age of 33 years.  142 patients (71%) were 
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positive for cutaneous allodynia 51 patients (45.9%) showed mild degree of cutaneous allodynia, 38 patients 
(34.2%)showed moderate and 22 patients (19.8%) showed severe degree of cutaneous allodynia
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The aim of our research was to find out the relation 
between migraine and cutaneous allodynia. For 
allodynia we used Cutaneous Allodynia Checklist (ASC), 
table-17 to describe the frequency and characteristics 
of cutaneous allodynia in migraine population.
Table-1:
12‐item Allodynia Symptom Checklist (ASC‐12)
MATERIALS AND METHODS:
This was a descriptive case study conducted in 
department of neurology, Pakistan Institute of Medical 
Sciences for a period of 1 year from June 2017 to May 
2018 after taking permission from ethical committee of 
the hospital. A total of 200 patients were enrolled using 
non probability consecutive sampling. Sample size was 
calculated using WHO sample size calculator. An 
informed written consent was taken from all the 
patients. All patients of both genders above age 13 
years of age with migraine diagnosed as having 
“Migraine without aura” or “Migraine with aura” 
according to the International Headache society 
criteria, ICHD-3 beta, were enrolled in this study16. 
Cutaneous allodynia was evaluated by using Allodynia 
Symptom Checklist that consisted of 12-items. 
Cutaneous allodynia severity was defined according to 
score i.e No allodynia if score was 0-2, mild allodynia if 
score was 3-5, moderate allodynia if score was 6-8 and 
severe allodynia with a score of 9 or more. The data 
was entered on a standard performa and analyzed by 
using SPSS version 17. Mean and standard deviations 
were calculated for numerical variables. Frequencies 
and percentages were calculated categorical variables. 
RESULTS:
A total of 200 patients were enrolled in this study. The 
mean age of the patient was 33 years. Out of 200 
patients 142 (71 %) were females and 58 (29 %) were 
males as shown in table 2. Out of 200 patients 111 
(55.5 %) had some symptoms of cutaneous allodynia 
while 89 patients (44.5 %) didn’t show any symptoms 
of cutaneous allodynia as shown in table-3. Out of 111 
patients who were positive for cutaneous allodynia 51 
patients (45.9%) showed mild degree of cutaneous 
allodynia, 38 patients (34.2%) showed moderate and 
22 patients (19.8%) showed severe degree of 
cutaneous allodynia as shown in table-4.
Table-2: Gender distribution
Table-3: Cutaneous Allodynia positive and negative 
patients.
Table-4: Severity of Cutaneous Allodynia.
DISCUSSION:
Cutaneous allodynia is the feeling of discomfort and 
pain to the stimuli that usually do no cause pain. It is 
one of the several complications of migraine that 
develop due to chronicity as the disease progresses 
and affect the outcome measures in disease course. 
The proposed reason for allodynia is the sensitization of 
the nociceptive neurons in central pain pathway. As 
disease progresses and its duration increases the 
frequency of allodynia also increases.  All patients were 
examined and interviews directly and by the authors 
themselves. By using the 12-items Allodynia Symptoms 
Checklist, we found the frequency percentage of 
cutaneous allodynia in migraine sufferers was up to 56 
percent with varying degrees of symptoms of allodynia 
ranging from mild to severe depending upon ASC-12 
items score. Our study is consistent with the findings of 
an international study by Lipton et al 17 that showed a 
presence of cutaneous allodynia up to 63% among 
migraineurs with severe allodynia present in 20.3% of 
migraineurs. Presence and severity of allodynia 
indicates the migraine severity actually indicating 
prompt treatment as the increased frequency of 
allodynia indicates the long term disease activity. Just 
like migraine headache that has many aggravated 
factors, cutaneous allodynia after sensitization involving 
the central process responds to even the trivial stimuli 
from inside as well as outside the brain. Young WB et al 
18 showed in their study that frequent migraine 
headache attacks are responsible for occurrence 
allodynia that favours the concept of sensitization 
leading to abnormal and enhanced dermal response to 
non irritating stimuli even. Prolonged duration of 
disorder and chronicity are related to higher 
percentages of derangements and alteration in 
processing of sensory stimuli in the cerebral cortex 19. 
So the proposed structural changes in 
trigeminovascular excitability pathway as well as some 
other pain-modulating systems in the brainstem are 
also thought to be involved in the process of happening 
of signs and symptoms of cutaneous allodynia.
In another study by Ashkenazi et al 20 on which they 
found the prevalence of allodynia in migraine patients 
up to 80%. Usually the patients become sensitive to 
pain even during attack free periods of migraine but as 
far as the allodynia is concerned when patients were 
enquired about abnormal dermal response they denied 
any symptoms of cutaneous allodynia during headache 
free periods suggesting its reversible nature.
LIMITATIONS
It is a single centre study. Frequency in non-migraine 
patients is not checked in this study. Associations of 
cutaneous allodynea especially with duration and 
severity of migraine as well as its impact on activities of 
daily living was not exercised. Validated scales for CA 
assessment not available in other languages.
CONCLUSION:
This study shows the presence and severity of allodynia 
in migraine population. Increased skin sensitivity can 
be determined by simple and relevant questioning 
about activities such as brushing hair, touching the 
scalp, shaving, and wearing glasses, contact lenses, 
earrings, or wearing tight clothes hurt patients during 
migraine attacks.
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Question: How often do you 
experience increased pain or 
an unpleasant sensation on 
your skin during your most 
severe type of headache 
when you engage each of the 
following? 
Does not 
apply to 
me 
Never Rarely Less than 
half of 
the 
time 
Half of 
the 
time or 
more 
 Score: 0  Score: 0  Score: 0  Score: 1 Score: 2 
Wearing a necklace      
Wearing earrings      
Wearing glasses      
Wearing tight clothes      
Wearing a pony tail      
Wearing contact lenses      
Shaving the face      
Taking a shower      
Combing the hair      
Resting the head on a pillow      
Exposure to cold      
Exposure to heat      
Total score:      
Sum of score:      
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informed written consent was taken from all the 
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Cutaneous allodynia severity was defined according to 
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score was 3-5, moderate allodynia if score was 6-8 and 
severe allodynia with a score of 9 or more. The data 
was entered on a standard performa and analyzed by 
using SPSS version 17. Mean and standard deviations 
were calculated for numerical variables. Frequencies 
and percentages were calculated categorical variables. 
RESULTS:
A total of 200 patients were enrolled in this study. The 
mean age of the patient was 33 years. Out of 200 
patients 142 (71 %) were females and 58 (29 %) were 
males as shown in table 2. Out of 200 patients 111 
(55.5 %) had some symptoms of cutaneous allodynia 
while 89 patients (44.5 %) didn’t show any symptoms 
of cutaneous allodynia as shown in table-3. Out of 111 
patients who were positive for cutaneous allodynia 51 
patients (45.9%) showed mild degree of cutaneous 
allodynia, 38 patients (34.2%) showed moderate and 
22 patients (19.8%) showed severe degree of 
cutaneous allodynia as shown in table-4.
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patients.
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DISCUSSION:
Cutaneous allodynia is the feeling of discomfort and 
pain to the stimuli that usually do no cause pain. It is 
one of the several complications of migraine that 
develop due to chronicity as the disease progresses 
and affect the outcome measures in disease course. 
Allodynia  ASC range 
None 
Mild 
Moderate 
0-2 
3-5 
6-8 
Severe  9 or more 
Percent %Frequency
Valid Male
 Female
 Total
58
142
200
29
71
100.0
Percent %Frequency
Valid Positive
 Negative
 Total
111
89
200
55.5
44.5
100.0
Percent %FrequencyCA
Negative
Mild
Moderate
Severe
Total
89
51
38
22
200
44.5
25.5
19.0
11.0
100.0
The proposed reason for allodynia is the sensitization of 
the nociceptive neurons in central pain pathway. As 
disease progresses and its duration increases the 
frequency of allodynia also increases.  All patients were 
examined and interviews directly and by the authors 
themselves. By using the 12-items Allodynia Symptoms 
Checklist, we found the frequency percentage of 
cutaneous allodynia in migraine sufferers was up to 56 
percent with varying degrees of symptoms of allodynia 
ranging from mild to severe depending upon ASC-12 
items score. Our study is consistent with the findings of 
an international study by Lipton et al 17 that showed a 
presence of cutaneous allodynia up to 63% among 
migraineurs with severe allodynia present in 20.3% of 
migraineurs. Presence and severity of allodynia 
indicates the migraine severity actually indicating 
prompt treatment as the increased frequency of 
allodynia indicates the long term disease activity. Just 
like migraine headache that has many aggravated 
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the central process responds to even the trivial stimuli 
from inside as well as outside the brain. Young WB et al 
18 showed in their study that frequent migraine 
headache attacks are responsible for occurrence 
allodynia that favours the concept of sensitization 
leading to abnormal and enhanced dermal response to 
non irritating stimuli even. Prolonged duration of 
disorder and chronicity are related to higher 
percentages of derangements and alteration in 
processing of sensory stimuli in the cerebral cortex 19. 
So the proposed structural changes in 
trigeminovascular excitability pathway as well as some 
other pain-modulating systems in the brainstem are 
also thought to be involved in the process of happening 
of signs and symptoms of cutaneous allodynia.
In another study by Ashkenazi et al 20 on which they 
found the prevalence of allodynia in migraine patients 
up to 80%. Usually the patients become sensitive to 
pain even during attack free periods of migraine but as 
far as the allodynia is concerned when patients were 
enquired about abnormal dermal response they denied 
any symptoms of cutaneous allodynia during headache 
free periods suggesting its reversible nature.
LIMITATIONS
It is a single centre study. Frequency in non-migraine 
patients is not checked in this study. Associations of 
cutaneous allodynea especially with duration and 
severity of migraine as well as its impact on activities of 
daily living was not exercised. Validated scales for CA 
assessment not available in other languages.
CONCLUSION:
This study shows the presence and severity of allodynia 
in migraine population. Increased skin sensitivity can 
be determined by simple and relevant questioning 
about activities such as brushing hair, touching the 
scalp, shaving, and wearing glasses, contact lenses, 
earrings, or wearing tight clothes hurt patients during 
migraine attacks.
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